Laboratoires Pierre Fabre S A Company Profile

12:15 EDT 19th March 2018 | BioPortfolio



Le Carla Burlats



News Articles [75 Associated News Articles listed on BioPortfolio]

Pierre Fabre out-licenses F17727

Pierre Fabre Pharmaceuticals has entered into a worldwide licensing agreement for it selective potassium…

Institut Curie, Pierre Fabre Partner on immuno-oncology

Institut Curie and the IRPF (Institut de Recherche Pierre Fabre) will collaborate on new therapeutic strategies to advance cancer treatment for patients. The objective of this novel partnership is to ...

Boston Pharmaceuticals gets global rights to preclinical cardio compound from Pierre Fabre

Pierre Fabre Group licensed Boston Pharmaceuticals Inc. exclusive worldwide rights to develop, manufacture, and commercialize its selective potassium channel blocker F17727 for atrial fibrillation. ...

Cellectar and Pierre Fabre extend PDC deal

New Triple Combination Therapy Boosts Colorectal Cancer Survival

Pierre Fabre and Array BioPharma’s combination therapy for colorectal cancer has improved progression-free survival in a Phase III trial. French pharma Pierre Fabre and American biopharma Array...

Institut Curie, Pierre Fabre partner to develop cancer immunotherapies

Laboratoires Pierre Fabre SA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15022018] Prices from USD $250

SummaryLaboratoires Pierre Fabre SA Pierre Fabre, a subsidiary of Pierre Fabre Foundation develops products and solutions ranging from health to beauty. Its product portfolio comprises wide range of c...

BMG Pharma S.r.l Announces the Launch of Its AFTACURE Gel and AFTACURE Spray under the ELGYDIUM CLINIC Brand as Cicalium Gel and Cicalium Spray by its Partner Pierre Fabre Medicament in France

BMG Pharma S.r.l., an Italian specialty pharmaceutical company is pleased to announce that its partner, Pierre Fabre Laboratories, the second-largest French private pharmaceutical...

PubMed Articles [18 Associated PubMed Articles listed on BioPortfolio]

The Pierre Robin Mandible is Hypoplastic and Morphologically Abnormal.

For Pierre Robin sequence (PRS) patients, there is incomplete characterization of 3D differences and effects of mandibular distraction osteogenesis (MDO) on the mandible compared to normal controls.

A comprehensive scoring system in correlation with perioperative airway management for neonatal Pierre Robin Sequence.

To evaluate a comprehensive scoring system which combines clinical manifestations of Pierre Robin Sequence (PRS) including severity of breathing difficulties, body weight and preoperative Cormack-Leha...

Postoperative Respiratory Complications After Cleft Palate Closure in Patients With Pierre Robin Sequence: Operative Considerations.

In cleft palate surgery, there is currently no consensus on the management of patients with Pierre Robin Sequence (PRS). The authors aimed to evaluate the treatment strategy of cleft palate in our cen...

Le blessé par attentat terroriste : Stéphane Mérat, Pierre Pasquier, Marie-Dominique Colas. Édition Arnette, 2017, 302 pages. ISBN: 978-2-7-7184-1481-2.

A Review on Ethno-Medicinal and Pharmacological Activities of Sphenocentrum jollyanum Pierre.

Sphenocentrum jollyanum Pierre is a member of a diverse family of plants known as Menispermaceae. They are famous for a plethora of important biological functions. S. jollyanum is a shrub native to th...

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Tolerance of D-pigment Versus Moisturizer in Hands' Lentigo Lesions With or Without Laser Therapy

Pierre Fabre Dermo-Cosmétique has commercialized a cosmetic product (D-pigment rich texture) for treatment of hyperpigmentation. The aim of this study is to evaluate the efficacy of D-pig...

Impact of Phonatory and Facial Morphology Disorders, on the Quality of Life of Adolescents With Pierre Robin Sequence

The study team has made the hypothesis that the intensity of the phonatory disorders (rhinolalia), and of the maxillo-mandibular growth anomalies (facial morphology), may have negative eff...

Early Treatment Outcomes in Pierre-Robin-Like Phenotype

In a longitudinal cohort study, we want to assess the effect of the pre-epiglottic baton plate, the main treatment approach currently used in Germany for Pierre-Robin-Like phenotype, on up...

Brainstem Dysfunction Involvement in the Pathogenesis of Pierre Robin Sequence

Introduction Pierre Robin Sequence, PRS, incidence is about one hundred births per year in France. The main neonatal clinical manifestations are secondary to airway obstruction and food di...

Clinical Study, Opened, of Cutaneous Acceptability of a Topic Product in Normal Conditions of Use

The measured product in this research is a product for topical use, Laboratoires Mercurochrome Reparador e Protetor. The expected benefit to the use of the product is the improvement in sk...

Companies [47 Associated Companies listed on BioPortfolio]

Pierre Fabre SA

Pierre Fabre group, France's second biggest independent pharmaceutical laboratory, achieved a turnover of 1.75 billion euros in 2008. Approximatively 10,000 people including 1,400 in the research ...

Laboratoires Pierre Fabre S A


Groupe Pierre Fabre

The Pierre Fabre Group, the second largest independent French pharmaceutical company and leader in the field of in-pharmacy dermo-cosmetics, employs about 10,000 people worldwide, including 1,400 ...


Located in France, close to the biotech heart of Geneva, the CIPF is a part of Pierre FABRE Laboratories (over 9000 people in France and overseas). Created in 1990, our Research Centre - 100 collabor...

Laboratoires Thea

Laboratoires Thea is the leading independent ophthalmic group in Europe. Founded in 1994, the company is a family business built on the heritage of over 150 years experience of the Chibret Family ...

More Information about "Laboratoires Pierre Fabre S A" on BioPortfolio

We have published hundreds of Laboratoires Pierre Fabre S A news stories on BioPortfolio along with dozens of Laboratoires Pierre Fabre S A Clinical Trials and PubMed Articles about Laboratoires Pierre Fabre S A for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Laboratoires Pierre Fabre S A Companies in our database. You can also find out about relevant Laboratoires Pierre Fabre S A Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record